🇺🇸 FDA
Patent

US 8124068

Recombinant intracellular pathogen immunogenic compositions and methods of use

granted A61KA61K2039/522A61K2039/523

Quick answer

US patent 8124068 (Recombinant intracellular pathogen immunogenic compositions and methods of use) held by The Regents of the University of California expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K2039/545, A61K39/04